293.73
+5.39(+1.87%)
Currency In USD
| Previous Close | 288.34 |
| Open | 288.21 |
| Day High | 293.81 |
| Day Low | 288.21 |
| 52-Week High | 293.81 |
| 52-Week Low | 199.92 |
| Volume | 481,760 |
| Average Volume | 912,959 |
| Market Cap | 43.01B |
| PE | 30.85 |
| EPS | 9.52 |
| Moving Average 50 Days | 267.82 |
| Moving Average 200 Days | 243.93 |
| Change | 5.39 |
If you invested $1000 in ResMed Inc. (RMD) 10 years ago, it would be worth $6,645.48 as of August 24, 2025 at a share price of $293.73. Whereas If you bought $1000 worth of ResMed Inc. (RMD) shares 5 years ago, it would be worth $1,725.29 as of August 24, 2025 at a share price of $293.73.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs
GlobeNewswire Inc.
Aug 21, 2025 1:00 PM GMT
Milestones underscore Resmed’s leadership and commitment to delivering life-changing health technology that people love Resmed AirTouch N30i Red Dot Awards Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards SAN DIEGO, Aug.
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio
GlobeNewswire Inc.
Aug 18, 2025 8:15 PM GMT
Mowad-Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations Her appointment brings over 30 years of strategic, commercial, and operational expertise in the pharmaceutical and broader healthcare industry,
Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025
GlobeNewswire Inc.
Jul 01, 2025 8:05 PM GMT
SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2025 on Thursday, July 31, 2025, after the New York Stock Exchange